Healthark Global Capability Centers (GCC)

India is uniquely positioned to lead the global #AI-driven revolution in pharma R&D! From a vast talent pool and cost efficiencies to thriving innovation ecosystems, robust government initiatives, and scalable infrastructure, the country is paving the way for cutting-edge #advancements in healthcare. Join the conversation on how #India is driving the future of AI in #pharma R&D. What opportunities do you see for innovation in this space? Share your thoughts! #Innovation #HealthcareAI #PharmaResearch #IndiaLeadership

AI is Transforming #DrugDevelopment As artificial intelligence (#AI) continues to reshape industries, the pharmaceutical sector is seeing some of the most exciting changes.?AI is poised to significantly reduce costs across the drug development lifecycle—from target identification to regulatory submission. Here’s what we can expect: 15-22% #CostReductions in the next 3-5 years 22-33% reductions in 5-7 years Up to 44-67% at peak?AI adoption! Discover the transformative impact of AI on drug development—saving costs and driving innovation. View the insights now! #AIinPharma #PharmaInnovation #DrugDevelopment #HealthcareInnovation #CostReduction #AIRevolution

India has emerged as a powerhouse in the global healthcare and #lifesciences sectors, transforming Global Capability Centers (#GCCs) from cost-saving hubs to innovation leaders. With advancements in #AI, data science, and #digital transformation, these centers are reshaping healthcare R&D and driving innovation worldwide. Discover how multinational companies are leveraging India’s growing talent pool to lead the charge in AI-driven #drugdiscovery, digital therapeutics, and personalized medicine. Read the full blog to explore this dynamic shift and the future of #healthcare in #India. https://lnkd.in/daWBaHRS #GlobalCapabilityCenters #HealthcareInnovation #GlobalBusiness #DigitalTransformation #LifeSciences

Evernorth Health Services, a Cigna Group arm, has opened its Global Capability Centre (#GCC) in Hyderabad, cementing India's role as a thriving hub for innovation and #global excellence. With plans to hire 300 employees by April 2025, this move strengthens the growing GCC ecosystem in India, creating new opportunities and driving economic growth. Hyderabad continues to lead the way in fostering global #partnerships. Learn more about the #expansion of Evernorth in Hyderabad & growth of GCCs in India here: https://lnkd.in/dKknffvF #GlobalCapabilityCentre #Hyderabad #Innovation #Growth #India #LifeSciences

Navigating the Complex Landscape of Pharma R&D The road to innovation in drug development has has become significantly steeper with skyrocketing clinical trial costs, declining #ROI, and mounting complexity. Explore how AI and advanced technologies are revolutionizing this space in our latest white paper "AI Infused Pharma R&D - India’s GCCs Leading the Global Charge" Visit our website to get full access to our latest whitepaper: https://lnkd.in/eku_cWPX #AIinPharma #HealthcareInnovation #PharmaceuticalR&D #AI

Healthark Insights was at ‘AI in Healthcare Summit - Road to BioAsia 2025’ that attracted over 250 attendees, including representatives from leading #healthcare companies, government officials, academia, and startups. "It's about the ecosystem moving forward together, where talent and technology converge. Progress requires experimentation, learning, and collaboration for transformation." - Sudeep Krishna, Co-founder & President at Healthark Insights We also launched our comprehensive white paper, created in collaboration with C4IR Telangana: "AI Infused Pharma R&D - India’s GCCs Leading the Global Charge," during the summit. Visit our website to get full access to our latest whitepaper: https://lnkd.in/eku_cWPX Read more about the summit here: https://lnkd.in/d857KCRn #AIinHealthcare #BioAsia2025 #HealthcareInnovation #LifeSciences #HealthTech #FutureofCare

Healthark Insights was honoured to be part of 'AI in Healthcare Summit: Road to BioAsia 2025' The event brought together visionaries from various ministries, distinguished keynote speakers, and thought leaders from prestigious organisations to explore the transformative power of #AI in healthcare. One of the standout sessions was the #panel discussion moderated by Healthark's Co-founder & President, Sudeep Krishna, 'Life Sciences #GCCs Driving Healthcare Innovation in India for the World', which highlighted how AI-driven advancements are reshaping the healthcare ecosystem globally. What’s your take on AI’s role in revolutionising #healthcare? Let us know in the comments! C4IR Telangana | Sudeep Krishna | Dr. Purav Gandhi | Ritu Baliyaa | Shivang Bhagat | Riya Doshi | Utkarsh Singh | Dr. Sharath Renukaradhya | Dr. Archita Srivastava #AIinHealthcare #BioAsia2025 #HealthcareInnovation #LifeSciences #HealthTech #FutureofCare

The pharmaceutical industry is rapidly embracing AI to address challenges such as high clinical trial costs, data complexity, and declining ROI. At the same time, the focus remains on reducing prices across the value chain.?In your opinion, what is the most crucial aspect AI should prioritize to create maximum impact in Pharma R&D? ?#PharmaR&D #AIinHealthcare #Innovation

Healthark Insights' Co-founder and President, Mr. Sudeep Krishna, moderated a dynamic panel discussion on 'Life Sciences GCCs Driving Healthcare Innovation in India for the World' at the 'AI in Healthcare Summit: Road to BioAsia 2025'. Panelists Mr. Mahesh Natarajan, Senior Director at Thermo Fisher Scientific, Mr. Mahesh Iyer, Head of Global Biometrics & Data Sciences at Bristol Myers Squibb (#BMS), Mr. Sairam Nair, Head of Global Competency Center at Sandoz, and Ms. Swapna Vadlamani (she/her/hers), Head of People Partnering India at Novartis, shared their experiences on establishing #GCCs and leveraging AI to drive innovation in healthcare. C4IR Telangana | Dr. Purav Gandhi | Ritu Baliyaa #AIinHealthcare #LifeSciences #GCC #HealthcareInnovation #BioAsia2025 #GlobalHealth #AI #HealthTech #Pharma

We are proud to launch our comprehensive white paper, jointly prepared with C4IR Telangana: "AI Infused Pharma R&D - India’s GCCs Leading the Global Charge" unveiled at the Road to BioAsia 2025: AI in Healthcare Summit The paper explores how #ArtificialIntelligence is transforming the pharmaceutical industry. AI is revolutionizing drug discovery, clinical trials, and #R&D processes, helping companies tackle rising costs, increasing trial complexity, and declining ROI. With global leaders like #Merck, Pfizer, and Novartis already making strides, India has emerged as a key player in this AI-driven evolution. Through its thriving Global Capability Centers (#GCCs), #India is accelerating drug development, optimizing trials, and driving innovation in the pharmaceutical sector. Visit our website to get full access to our latest whitepaper: https://lnkd.in/eku_cWPX Shakthi M Nagappan | Dean Ho | Sridhar Babu Duddilla | Nageshwar Reddy | Jayesh Ranjan | Sudeep Krishna | Dr. Purav Gandhi | Ritu Baliyaa #AIinPharma #HealthcareInnovation #PharmaceuticalR&D #AI